According to reports, Guangming daily Harbin Veterinary Research Institute of China Academy of agricultural sciences, recently sent messages, located in the Institute's national avian influenza reference laboratory responsible for the major project of the Ministry of science and technology — the "highly pathogenic avian influenza control technological research and development" project recently achieved a major breakthrough. The project contains "H5N1 subtype of avian influenza vaccine development and application development," "the H5 subtype of avian influenza recombinant fowlpox virus genetic vaccine
Industrialization and its key technology research, "" H5N2 subtypes of avian influenza vaccine new technology research, "and" highly pathogenic avian influenza virus subtypes and identification technology research "and other topics, 4 total recently adopted the acceptance of the Ministry of science and technology. Of these, "H5N1 subtype in the reorganization of the avian influenza virus inactivated vaccines" and "the H5 subtype of avian influenza recombinant fowlpox virus vector vaccine" reached the international advanced level, access to the Department of Agriculture's agricultural transgenic biological safety certificate and the certificate of registration of new veterinary drug.
Relevant experts, H5N1 subtype in the reorganization of the avian influenza virus vaccine development, successfully overcome the highly pathogenic avian influenza vaccine technology bottlenecks, while addressing the increasing waterfowl avian influenza immunization effect of technical challenges. To the virus as a drug developed by vaccination against avian influenza in birds and mammals is very safe, Antigen targeted, high efficiency, on the effective immune protection period is 10 months.
Currently, Harbin Veterinary Research Institute in avian influenza diagnostic technology also won the encouraging progress, the successful establishment of the avian influenza virus diagnosis indirect immunofluorescence technique, direct detection of clinical disease of indirect immunofluorescence diagnosis technology, as well as the avian influenza virus Antigen capture technology and the diagnosis of avian influenza virus common technologies and successful 3 respectively Assembly Kit. The establishment of these technologies, will greatly improve our response to avian influenza outbreak in a rapid reaction capability.